- $2.68bn
- $3.40bn
- $822.45m
- 89
- 48
- 14
- 49
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 22.99 | ||
| PEG Ratio (f) | 1.01 | ||
| EPS Growth (f) | 29.54% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.85 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.89 | ||
| EV to EBITDA | 18.36 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.56% | ||
| Return on Equity | 0.05% | ||
| Operating Margin | 7.43% | ||
Financial Summary
| Year End 31st May | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 414.19 | 418.17 | 468.46 | 527.16 | 822.45 | 923.97 | 962.87 | 15.63% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -5.61 | -1.01 | +0.96 | -21.31 | -74.21 | +298.89 | +19.57 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Directors
- James Borel CHM (66)
- John Adent PRE (53)
- Steven Quinlan CFO (58)
- Jerome Hagedorn VPR (55)
- Doug Jones VPR (51)
- Jason Lilly VPR (47)
- William Boehm IND (75)
- Ronald Green IND (61)
- Ralph Rodriguez IND (54)
- James Tobin IND (66)
- Darci Vetter IND (48)
- Catherine Woteki IND (74)
- Last Annual
- May 31st, 2023
- Last Interim
- February 29th, 2024
- Incorporated
- June 30th, 1981
- Public Since
- August 23rd, 1989
- No. of Shareholders
- 580
- No. of Employees
- 2,640
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 216,607,746
- Address
- 620 Lesher Pl, LANSING, 48912-1509
- Web
- https://www.neogen.com/
- Phone
- +1 5173729200
- Auditors
- BDO USA, LLP
Upcoming Events for NEOG
Q1 2025 Neogen Corp Earnings Release
Similar to NEOG
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Neogen share price?
As of Today at 19:15 UTC, shares in Neogen are trading at $12.38. This share price information is delayed by 15 minutes.
How has the Neogen share price performed this year?
Shares in Neogen last closed at $12.38 and the price had moved by -25.6% over the past 365 days. In terms of relative price strength the Neogen share price has underperformed the S&P500 Index by -39.92% over the past year.
What are the analyst and broker recommendations for Neogen?
The overall consensus recommendation for Neogen is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Neogen dividend yield?
Neogen does not currently pay a dividend.
Does Neogen pay a dividend?
Neogen does not currently pay a dividend.
When does Neogen next pay dividends?
Neogen does not currently pay a dividend.
How do I buy Neogen shares?
To buy shares in Neogen you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Neogen?
As of the previous close price of $12.38, shares in Neogen had a market capitalisation of $2.68bn.
Where are Neogen shares listed?
Here are the trading details for Neogen:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: NEOG
What kind of share is Neogen?
Based on an overall assessment of its quality, value and momentum Neogen is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Neogen share price forecast for 2024?
The analyst consensus target price for shares in Neogen is $19.00. That is 53.47% above the last closing price of $12.38.
Analysts covering Neogen currently have a consensus Earnings Per Share (EPS) forecast of $0.46 for the next financial year.
What is the trend in the Neogen share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Neogen. Over the past six months, its share price has underperformed the S&P500 Index by -31.69%.
As of the last closing price of $12.38, shares in Neogen were trading -32.4% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Neogen PE Ratio?
The Neogen PE ratio based on its reported earnings over the past 12 months is 22.99. The shares last closed at $12.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Neogen?
Neogen's management team is headed by:
- James Borel - CHM
- John Adent - PRE
- Steven Quinlan - CFO
- Jerome Hagedorn - VPR
- Doug Jones - VPR
- Jason Lilly - VPR
- William Boehm - IND
- Ronald Green - IND
- Ralph Rodriguez - IND
- James Tobin - IND
- Darci Vetter - IND
- Catherine Woteki - IND